Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.

Wiener klinische Wochenschrift
Peter ValentGünther Gastl

Abstract

Chronic myeloid leukemia (CML) is a stem cell disease characterized by the BCR/ABL oncoprotein. The ABL kinase inhibitor imatinib is effective in most patients and considered standard first-line therapy. However, not all patients show a long-lasting response to this drug. In fact, resistance against imatinib has been described and is an emerging clinical problem in CML. For these patients, novel multi-kinase inhibitors such as nilotinib or dasatinib as well as stem cell transplantation, represent alternative treatment options. The decision concerning second-line therapies and selection of drugs is usually based on the presence and type of BCR/ABL mutations, the phase of disease, other disease-related factors as well as patient-related factors including age, co-morbidity, and pharmacologic determinants. The current article provides an overview on diagnostic and therapeutic strategies for patients with treatment-naïve and imatinib-resistant CML, together with proposed algorithms that were discussed and approved by members of the CML platform of the Austrian Society for Hematology and Oncology (OGHO) in 2007 and 2008. The resulting recommendations should assist in diagnosis and prognostication in CML, follow-up and disease-monitor...Continue Reading

References

Nov 1, 1991·British Journal of Haematology·J M HernándezA López-Borrasca
Jan 1, 1990·The American Journal of Medicine·H M KantarjianK B McCredie
Jan 23, 1986·The New England Journal of Medicine·J M GoldmanJ Hows
Jul 1, 1983·British Journal of Haematology·D DouerM J Cline
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
May 25, 2002·British Journal of Haematology·Andreas L PetzerGuenther Gastl
Feb 4, 2003·Seminars in Hematology·J HasfordUNKNOWN Collaborative CML Prognostic Factors Project Group
Feb 4, 2003·Seminars in Hematology·Jorge Cortes, Hagop Kantarjian
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Jun 5, 2003·Seminars in Hematology·Catherine Roche-Lestienne, Claude Preudhomme
Oct 10, 2003·The New England Journal of Medicine·Tim P HughesUNKNOWN International Randomised Study of Interferon versus STI571 (IRIS) Study Group
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E AbruzzeseElena Campione
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bin PengRenaud Capdeville
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Jul 24, 2004·Hematology/oncology Clinics of North America·Francis J GilesSusan M O'Brien
Feb 16, 2005·Cancer Cell·Ellen WeisbergJames D Griffin
Mar 24, 2005·Clinical and Laboratory Haematology·J-F LesesveT Lecompte

❮ Previous
Next ❯

Citations

Feb 9, 2011·Annals of Hematology·Karolien Anne BeelPeter Vandenberghe
Oct 2, 2013·Wiener medizinische Wochenschrift·Thomas LionGünther Gastl
Oct 12, 2010·Wiener klinische Wochenschrift·Stefan SchmidtUNKNOWN ASHO CML registry
Nov 7, 2009·European Journal of Internal Medicine·Alexandra BoehmPeter Valent
Jul 6, 2010·European Journal of Clinical Investigation·Peter Valent
Apr 18, 2015·Journal of Hematology & Oncology·Axel SchulenburgPeter Valent

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Cancer
Mary-Ann Bjornsti, Peter J Houghton
Current Opinion in Pharmacology
Shile Huang, Peter J Houghton
Cancer Biology & Therapy
Shile HuangPeter J Houghton
© 2021 Meta ULC. All rights reserved